The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels

✍ Scribed by Robert M. Sargis; Brian A. Neel; Clifton O. Brock; Yuxi Lin; Allison T. Hickey; Daniel A. Carlton; Matthew J. Brady

• Book ID: 116271104
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 905 KB
• Volume: 1822
• Category: Article
• ISSN: 0925-4439
• DOI: 10.1016/j.bbadis.2012.02.015